These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1866059)

  • 1. Phosphate removal rate: a comparative study of five high-flux dialysers.
    Chauveau P; Poignet JL; Kuno T; Bonete R; Kerembrun A; Naret C; Delons S; Man NK; Rist E
    Nephrol Dial Transplant; 1991; 6 Suppl 2():114-5. PubMed ID: 1866059
    [No Abstract]   [Full Text] [Related]  

  • 2. [Factors which influence phosphorus removal in hemodialysis].
    Gallar P; Ortiz M; Ortega O; Rodríguez I; Seijas V; Carreño A; Oliet A; Vigil A
    Nefrologia; 2007; 27(1):46-52. PubMed ID: 17402879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Washout of water-soluble vitamins and of homocysteine during haemodialysis: effect of high-flux and low-flux dialyser membranes.
    Heinz J; Domröse U; Westphal S; Luley C; Neumann KH; Dierkes J
    Nephrology (Carlton); 2008 Oct; 13(5):384-9. PubMed ID: 18518942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
    Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
    Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients.
    Zehnder C; Gutzwiller JP; Renggli K
    Clin Nephrol; 1999 Sep; 52(3):152-9. PubMed ID: 10499310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of treatment time with high flux postdilutional hemofiltration (HF).
    Mion C; Beau MC; Deschodt G; Gullberg CA; Ramperez P; Shaldon S
    Proc Clin Dial Transplant Forum; 1979; 9():63-5. PubMed ID: 552056
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemodiafiltration using a polysulfone membrane, its ultrafiltration characteristics and biocompatibility].
    Iarmolinskiĭ IS; Stetsiuk EA; Iarmagomedov AA
    Urol Nefrol (Mosk); 1987; (2):45-9. PubMed ID: 3590419
    [No Abstract]   [Full Text] [Related]  

  • 8. beta 2-Microglobulin and other low molecular weight proteins in haemodiafiltrates and in haemofiltrates.
    Montali U; Pilone N; Cioni L; Ronca G
    Int J Tissue React; 1984; 6(1):71-4. PubMed ID: 6370888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PC-PE hollow-fiber membrane. Structure, performance characteristics and manufacturing.
    Göhl H; Raff M; Harttig H; Deppisch R
    Blood Purif; 1986; 4(1-3):23-31. PubMed ID: 3730157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical response to maintenance hemodiafiltration.
    Henderson LW; Silverstein ME; Ford CA; Lysaght MJ
    Kidney Int Suppl; 1975 Jan; (2):58-63. PubMed ID: 1057694
    [No Abstract]   [Full Text] [Related]  

  • 11. Adequacy of haemodiafiltration.
    Surian M; Malberti F; Corradi B; Orlandini G; Varini E; Colussi G; Minetti L
    Nephrol Dial Transplant; 1989; 4(1):32-6. PubMed ID: 2494595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients.
    Voormolen N; Noordzij M; Grootendorst DC; Beetz I; Sijpkens YW; van Manen JG; Boeschoten EW; Huisman RM; Krediet RT; Dekker FW;
    Nephrol Dial Transplant; 2007 Oct; 22(10):2909-16. PubMed ID: 17517792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphate removal during dialysis--does the membrane matter?
    Ritz E
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S57-60. PubMed ID: 7923986
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sequential ultrafiltration with hemodialysis in treating chronic kidney failure].
    Kulakov GP; Konovalov GA; Melikian AM; Makarova KM
    Urol Nefrol (Mosk); 1983; (1):34-9. PubMed ID: 6829090
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of transcutaneous electrical muscle stimulation and passive cycling movements on blood pressure and removal of urea and phosphate during hemodialysis.
    Farese S; Budmiger R; Aregger F; Bergmann I; Frey FJ; Uehlinger DE
    Am J Kidney Dis; 2008 Oct; 52(4):745-52. PubMed ID: 18487001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
    Pellicano R; Polkinghorne KR; Kerr PG
    Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term plasma phosphate behaviour in biofiltration.
    Rocco A; Pitzorno F; Pecorari M; Beltram E; Barnaba A; Barduagni S
    Int J Artif Organs; 1986 Dec; 9 Suppl 3():99-101. PubMed ID: 3557686
    [No Abstract]   [Full Text] [Related]  

  • 18. [Kinetic of calcium, phosphate, magnesium and PTH variations during hemodiafiltration].
    Rius A; Hernández-Jaras J; Pons R; García Pérez H; Torregrosa E; Sánchez Canel JJ; Fenollosa MA; Pin MT; Tamarit E; Calvo C
    Nefrologia; 2007; 27(5):593-8. PubMed ID: 18045035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ways of intensification of hemodialysis therapy].
    Filiptsev PIa; Kirkhman VV; Timokhov VS
    Ter Arkh; 1988; 60(6):44-7. PubMed ID: 3206368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reverse mid-dilution: new way to remove small and middle molecules as well as phosphate with high intrafilter convective clearance.
    Santoro A; Ferramosca E; Mancini E; Monari C; Varasani M; Sereni L; Wratten M
    Nephrol Dial Transplant; 2007 Jul; 22(7):2000-5. PubMed ID: 17405791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.